Clinical Trials
35 trialsPhase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Presage Biosciences
Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)
University of Iowa
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
Indiana University
Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy
Thomas Jefferson University
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
5-ALARMS
University of Colorado, Denver
VARTUTRACE
Var2 Pharmaceuticals
Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma
University of California, Irvine
Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
Memorial Sloan Kettering Cancer Center
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
Jonsson Comprehensive Cancer Center
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma
University of Rochester
CLIC-YYC-GPNMB
University of Calgary
SPS-Q2
University of Calgary
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
University of South Florida
TOASTIT
Mayo Clinic
PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
Presage Biosciences
Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma
University of Southern California
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
Shanghai Yunying Medical Technology
Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
Base Therapeutics (Shanghai) Co., Ltd.
Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma
Xiangya Hospital of Central South University
MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma
HRYZ Biotech Co.
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors
Shanghai Yunying Medical Technology
Liposomal Bupivacaine (Exparel) in Sarcomas
Wake Forest University Health Sciences
Gemcitabine With Ascorbate Including Adolescents
University of Iowa
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia
Presage Biosciences
Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Combination Chemotherapy in Treating Patients With Sarcoma
Mayo Clinic
Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
National Institutes of Health Clinical Center (CC)
K5
Siemens Molecular Imaging